Literature DB >> 17671359

High-resolution structures of bacterially expressed soluble human CD59.

Kirstin J Leath1, Steven Johnson, Pietro Roversi, Timothy R Hughes, Richard A G Smith, Lloyd Mackenzie, B Paul Morgan, Susan M Lea.   

Abstract

CD59 is a membrane-bound glycoprotein that protects host cells from lysis by inhibiting the terminal pathway of complement, preventing the formation and insertion of the membrane attack complex (MAC). Crystals of bacterially expressed and nonglycosylated recombinant soluble human CD59 have been obtained from three crystallization conditions, each of which gave rise to a distinct crystal form. Each crystal form led to a crystal structure at high resolution (1.15, 1.35 and 1.8 A). In one of these structures the electron-density map shows an as yet unidentified small molecule in the predicted C8/C9-binding site. The presence/absence of this ligand is linked to alternate conformations of the amino acids implicated in C8/C9 binding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671359      PMCID: PMC2335151          DOI: 10.1107/S1744309107033477

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  25 in total

1.  A study of human DAF, CD59, MCP transgene in xenotransplantation.

Authors:  S Chen; G Chen; C C Cai; X M Wang; H Guo; S Q Shen; H Wang; Y Wu; G X Li; J Huang; W X Li; Q X Wei; F Z Sun
Journal:  Transplant Proc       Date:  2001 Nov-Dec       Impact factor: 1.066

2.  CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Authors:  Imre Farkas; Lajos Baranyi; Yasushige Ishikawa; Noriko Okada; Csaba Bohata; Denes Budai; Atsuo Fukuda; Masaki Imai; Hidechika Okada
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

3.  The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.

Authors:  H Ninomiya; P J Sims
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

4.  Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.

Authors:  K P Murray; S Mathure; R Kaul; S Khan; L F Carson; L B Twiggs; M G Martens; A Kaul
Journal:  Gynecol Oncol       Date:  2000-02       Impact factor: 5.482

5.  Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT.

Authors:  E Blanc; P Roversi; C Vonrhein; C Flensburg; S M Lea; G Bricogne
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

6.  A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.

Authors:  S Tomlinson; M B Whitlow; V Nussenzweig
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

7.  The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.

Authors:  S A Rollins; P J Sims
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

8.  CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.

Authors:  S Chen; T Caragine; N K Cheung; S Tomlinson
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

9.  Structure-function relationships of the complement regulatory protein, CD59.

Authors:  J Petranka; J Zhao; J Norris; N B Tweedy; R E Ware; P J Sims; W F Rosse
Journal:  Blood Cells Mol Dis       Date:  1996       Impact factor: 3.039

10.  Structure of a soluble, glycosylated form of the human complement regulatory protein CD59.

Authors:  C M Fletcher; R A Harrison; P J Lachmann; D Neuhaus
Journal:  Structure       Date:  1994-03-15       Impact factor: 5.006

View more
  15 in total

1.  4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells.

Authors:  Mikhail Linetsky; Karina S Bondelid; Sofiya Losovskiy; Vadym Gabyak; Mario J Rullo; Thomas I Stiadle; Vasu Munjapara; Priyali Saxena; Duoming Ma; Yu-Shiuan Cheng; Andrew M Howes; Emeka Udeigwe; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2018-07-09       Impact factor: 3.739

2.  NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1.

Authors:  Ekaterina N Lyukmanova; Zakhar O Shenkarev; Mikhail A Shulepko; Konstantin S Mineev; Dieter D'Hoedt; Igor E Kasheverov; Sergey Yu Filkin; Alexandra P Krivolapova; Helena Janickova; Vladimir Dolezal; Dmitry A Dolgikh; Alexander S Arseniev; Daniel Bertrand; Victor I Tsetlin; Mikhail P Kirpichnikov
Journal:  J Biol Chem       Date:  2011-01-20       Impact factor: 5.157

3.  Ultratight crystal packing of a 10 kDa protein.

Authors:  Sergio Trillo-Muyo; Andrius Jasilionis; Marcin J Domagalski; Maksymilian Chruszcz; Wladek Minor; Nomeda Kuisiene; Joan L Arolas; Maria Solà; F Xavier Gomis-Rüth
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-02-16

4.  Structure of lipoprotein lipase in complex with GPIHBP1.

Authors:  Rishi Arora; Amitabh V Nimonkar; Daniel Baird; Chunhua Wang; Chun-Hao Chiu; Patricia A Horton; Susan Hanrahan; Rose Cubbon; Stephen Weldon; William R Tschantz; Sascha Mueller; Reto Brunner; Philipp Lehr; Peter Meier; Johannes Ottl; Andrei Voznesensky; Pramod Pandey; Thomas M Smith; Aleksandar Stojanovic; Alec Flyer; Timothy E Benson; Michael J Romanowski; John W Trauger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-09       Impact factor: 11.205

5.  Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.

Authors:  Stephanie E Wickham; Eileen M Hotze; Allison J Farrand; Galina Polekhina; Tracy L Nero; Stephen Tomlinson; Michael W Parker; Rodney K Tweten
Journal:  J Biol Chem       Date:  2011-04-20       Impact factor: 5.157

6.  Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic islets.

Authors:  Ewelina Golec; Alexander Ekström; Maciej Noga; Muhmmad Omar-Hmeadi; Per-Eric Lund; Bruno O Villoutreix; Ulrika Krus; Katarzyna Wozniak; Olle Korsgren; Erik Renström; Sebastian Barg; Ben C King; Anna M Blom
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-06       Impact factor: 12.779

7.  Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.

Authors:  Iain W Chalmers; Colin M Fitzsimmons; Martha Brown; Christine Pierrot; Frances M Jones; Jakub M Wawrzyniak; Narcis Fernandez-Fuentes; Edridah M Tukahebwa; David W Dunne; Jamal Khalife; Karl F Hoffmann
Journal:  PLoS Negl Trop Dis       Date:  2015-07-06

Review 8.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

9.  Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59.

Authors:  Steven Johnson; Nicholas J Brooks; Richard A G Smith; Susan M Lea; Doryen Bubeck
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

10.  Comparative studies of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1: evidence for a eutherian mammalian origin for the GPIHBP1 gene from an LY6-like gene.

Authors:  Roger S Holmes; Laura A Cox
Journal:  3 Biotech       Date:  2011-10-18       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.